文献速递衰弱、肌少症与跌倒老年慢病共病管理

帕金森病中的肌少症:不同诊断标准的比较及其与疾病严重程度的关联

Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity.
PubMed 文献 · J Am Med Dir Assoc · 2018-02-12

本研究为横断面观察研究,纳入210例特发性帕金森病老年患者,采用三种国际标准评估肌少症患病率并检验标准间一致性。结果显示肌少症患病率男性为28.5%-40.7%、女性为17.5%-32.5%,标准间一致性差,严重肌少症与帕金森病严重程度相关(OR 2.30,95%CI 1.15-4.58)。

要点

  • 帕金森病老年患者中肌少症常见,严重肌少症约占五分之一。
  • 三种国际标准诊断肌少症的一致性差,尤其体现在检出而非排除上。
  • 严重肌少症与帕金森病严重程度独立相关。

核心结论

  • 肌少症在帕金森病老年患者中普遍存在,严重肌少症约每5例患者中可诊断1例。
  • 三种国际标准诊断肌少症的一致性差,尤其在检出肌少症方面不一致更明显。
  • 严重肌少症与帕金森病严重程度存在显著关联。

研究设计与样本

  • 横断面观察研究,在老年日间医院开展。
  • 纳入210例特发性帕金森病老年患者,平均年龄73岁,女性占38%。
  • 通过双能X线吸收法评估身体成分,测量握力和步行速度。
  • 分别采用美国国立卫生研究院基金会、欧洲老年人肌少症工作组和国际工作组三种标准定义肌少症。
  • 使用Cohen kappa统计量检验标准间一致性。

主要发现

  • 肌少症患病率男性为28.5%-40.7%,女性为17.5%-32.5%。
  • 严重肌少症患病率男性为16.8%-20.0%,女性为11.3%-18.8%。
  • 严重肌少症与帕金森病严重程度相关(比值比2.30,95%置信区间1.15-4.58)。

关键数值与推荐

  • 肌少症定义采用美国国立卫生研究院基金会、欧洲老年人肌少症工作组和国际工作组三种标准。
  • 严重肌少症与帕金森病严重程度的关联:比值比2.30(95%CI 1.15-4.58)。

临床怎么用

  • 在老年帕金森病患者中应关注肌少症的筛查与评估。
  • 不同诊断标准间一致性差,临床选择标准时需注意其检出差异。
  • 严重肌少症与帕金森病严重程度相关,提示对重症患者应加强肌少症管理。

局限性

  • 横断面设计无法推断因果关系。
  • 研究在老年日间医院开展,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In Parkinson disease (PD), sarcopenia may represent the common downstream pathway that from motor and nonmotor symptoms leads to the progressive loss of resilience, frailty, and disability. Here we (1) assessed the prevalence of sarcopenia in older adults with PD using 3 different criteria, testing their agreement, and (2) evaluated the association between PD severity and sarcopenia. DESIGN: Cross-sectional, observation study. SETTING: Geriatric day hospital. PARTICIPANTS: Older adults with idiopathic PD. MEASUREMENTS: Body composition was evaluated through dual energy x-ray absorptiometry. Handgrip strength and walking speed were measured. Sarcopenia was operationalized according to the Foundation for the National Institutes of Health, the European Working Group on Sarcopenia in Older Persons, and the International Working Group. Cohen k statistics was used to test the agreement among criteria. RESULTS: Among the 210 participants (mean age 73 years; 38% women), the prevalence of sarcopenia was 28.5%-40.7% in men and 17.5%-32.5% in women. The prevalence of severe sarcopenia was 16.8%-20.0% in men and 11.3%-18.8% in women. The agreement among criteria was poor. The highest agreement was obtained between the European Working Group on Sarcopenia in Older Persons (severe sarcopenia) and International Working Group criteria (k = 0.52 in men; k = 0.65 in women; P < .01 for both). Finally, severe sarcopenia was associated with PD severity (odds ratio 2.30; 95% confidence interval 1.15-4.58). CONCLUSIONS: Sarcopenia is common in PD, with severe sarcopenia being diagnosed in 1 in every 5 patients with PD. We found a significant disagreement among the 3 criteria evaluated, in detecting sarcopenia more than in ruling it out. Finally, sarcopenia is associated with PD severity. Considering its massive prevalence, further studies should address the prognosis of sarcopenia in PD.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Vetrano DL, Pisciotta MS, Laudisio A, et al. Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity. J Am Med Dir Assoc. 2018. PMID: 29396191. doi:10.1016/j.jamda.2017.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。